#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4624654	F	Cytotoxicity against human patient derived GBM cells assessed as reduction in cell viability measured after 48 hrs by Hoechst staining based assay	Homo sapiens	3		cell-based format	Scientific Literature
2.	ALA4624655	F	Synergistic cytotoxicity against human patient derived GBM cells assessed as reduction in cell viability measured after 48 hrs in presence of temozolomide by Hoechst staining based assay	Homo sapiens	3		cell-based format	Scientific Literature
3.	ALA4624656	A	Substrate activity at OATP in human patient derived GBM cells assessed as protein-mediated drug uptake at 1 uM preincubated with 3,4-DHB for 1 hr followed by compound treatment measured after 1 hr by Hoechst staining based fluorescence microscopy	Homo sapiens	1		assay format	Scientific Literature
4.	ALA4624657	A	Substrate activity at OATP in human patient derived GBM cells assessed as protein-mediated drug uptake at 1 uM preincubated with sodium tauro-cholic acid for 30 mins followed by compound treatment measured after 1 hr by Hoechst staining based fluorescence microscopy	Homo sapiens	1		assay format	Scientific Literature
5.	ALA4624658	F	Ratio of EC50 for cytotoxicity against human patient derived GBM assessed as reduction in cell viability measured after 48 hrs by Hoechst staining based assay to EC50 for synergistic cytotoxicity against human patient derived GBM assessed as reduction in cell viability measured after 48 hrs in presence of temozolomide by Hoechst staining based assay	Homo sapiens	1		cell-based format	Scientific Literature
6.	ALA4624659	F	Antiproliferative activity against human patient derived GBM cells assessed as reduction in cell proliferation measured after 48 hrs by Edu incorporation assay	Homo sapiens	3		cell-based format	Scientific Literature
7.	ALA4624660	F	Synergistic antiproliferative activity against human patient derived GBM cells assessed as reduction in cell proliferation measured after 48 hrs in presence of temozolomide by Edu incorporation assay	Homo sapiens	3		cell-based format	Scientific Literature
8.	ALA4624662	F	Potency index, ratio of rucaparib IC50 to test compound IC50 for human patient derived GBM cells assessed as reduction in cell viability measured after 48 hrs by Hoechst staining based assay	Homo sapiens	1		cell-based format	Scientific Literature
9.	ALA4624663	F	Potency index, ratio of IR-786 IC50 to test compound IC50 for human patient derived GBM cells assessed as reduction in cell viability measured after 48 hrs by Hoechst staining based assay	Homo sapiens	1		cell-based format	Scientific Literature
10.	ALA4624664	F	Potency index, ratio of IR-786 IC50 to test compound IC50 for synergistic cytotoxicity against human patient derived GBM cells assessed as reduction in cell viability measured after 48 hrs in presence of temozolomide by Hoechst staining based assay	Homo sapiens	1		cell-based format	Scientific Literature
11.	ALA4624665	F	Antiproliferative activity against human patient derived GBM cells assessed as reduction in cell proliferation measured after 48 hrs by Edu incorporation assay relative to compound alone	Homo sapiens	2		cell-based format	Scientific Literature